<code id='32880C6C50'></code><style id='32880C6C50'></style>

<acronym id='32880C6C50'></acronym>

<center id='32880C6C50'><center id='32880C6C50'><tfoot id='32880C6C50'></tfoot></center><abbr id='32880C6C50'><dir id='32880C6C50'><tfoot id='32880C6C50'></tfoot><noframes id='32880C6C50'>

<optgroup id='32880C6C50'><strike id='32880C6C50'><sup id='32880C6C50'></sup></strike><code id='32880C6C50'></code></optgroup>

<b id='32880C6C50'><label id='32880C6C50'><select id='32880C6C50'><dt id='32880C6C50'><span id='32880C6C50'></span></dt></select></label></b><u id='32880C6C50'></u>

~~<i id='32880C6C50'><strike id='32880C6C50'><tt id='32880C6C50'><pre id='32880C6C50'></pre></tt></strike></i>~~

explore

author entertainment

2025-09-28 16:56:46

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout LOUD Podcast: Lilly's obesity drug, the power of radiation
Next article： In Memoriam: Notable people who died in 2023

Tags

Leave your comment

fashion

Surprise medical billing ban raises prices elsewhere

Wikipedia

In Memoriam: Notable people who died in 2023

2025-09-28 16:38

Weight loss drugs aren’t covered by Obamacare. That may change

fashion

United colonoscopy coverage change 'may cost lives,' doctors say

2025-09-28 15:42